ATE109780T1 - Heterocyclische verbindungen und antiulkusmittel. - Google Patents

Heterocyclische verbindungen und antiulkusmittel.

Info

Publication number
ATE109780T1
ATE109780T1 AT89102635T AT89102635T ATE109780T1 AT E109780 T1 ATE109780 T1 AT E109780T1 AT 89102635 T AT89102635 T AT 89102635T AT 89102635 T AT89102635 T AT 89102635T AT E109780 T1 ATE109780 T1 AT E109780T1
Authority
AT
Austria
Prior art keywords
heterocyclic compounds
antiulcic
agents
ulcer
prophylaxis
Prior art date
Application number
AT89102635T
Other languages
English (en)
Inventor
Shigeru Matsutani
Yukio Mizushima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE109780T1 publication Critical patent/ATE109780T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT89102635T 1988-02-18 1989-02-16 Heterocyclische verbindungen und antiulkusmittel. ATE109780T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3613088 1988-02-18

Publications (1)

Publication Number Publication Date
ATE109780T1 true ATE109780T1 (de) 1994-08-15

Family

ID=12461201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89102635T ATE109780T1 (de) 1988-02-18 1989-02-16 Heterocyclische verbindungen und antiulkusmittel.

Country Status (9)

Country Link
US (1) US4927829A (de)
EP (1) EP0329126B1 (de)
JP (1) JP2668259B2 (de)
KR (1) KR950008313B1 (de)
AT (1) ATE109780T1 (de)
AU (1) AU615033B2 (de)
CA (1) CA1329389C (de)
DE (1) DE68917333T2 (de)
ES (1) ES2061749T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
HU209793B (en) * 1990-09-25 1994-11-28 Chinoin Gyogyszer Es Vegyeszet Process for the production of pyrido[1,2-a]pyrimidine-derivatives and pharmaceutical compositions containing the same
DE10050661A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Substituierte 3,4-Dihydro-pyrimido[1,2-a]pyrimidine und 3,4-Dihydro-pyrazino[1,2-a]pyrimidine
EP1558585B1 (de) * 2002-10-04 2013-09-25 Prana Biotechnology Limited Neurologisch aktive verbindungen
US7767335B2 (en) * 2003-05-16 2010-08-03 The United States Of America As Represented By The Secretary Of The Navy High-voltage battery switch
WO2008074068A1 (en) * 2006-12-20 2008-06-26 Prana Biotechnology Limited Substituted quinoline derivatives as antiamyloidogeneic agents
BR112020021469A2 (pt) * 2018-04-20 2021-01-19 Virginia Tech Intellectual Properties, Inc. Imidazopiridinas úteis como desacopladores mitocondriais

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527931B2 (en) * 1979-05-08 1983-03-31 Farmitalia Carlo Erba S.P.A. Substituted pyrido(1,2-a)pyrimidines
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
DK169580B1 (da) * 1985-09-25 1994-12-12 Shionogi & Co 9-(substitueret thio)-4H-pyrido[1,2-a]pyrimidin-4-on-derivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende sådanne derivater

Also Published As

Publication number Publication date
AU2993789A (en) 1989-08-24
AU615033B2 (en) 1991-09-19
EP0329126A1 (de) 1989-08-23
CA1329389C (en) 1994-05-10
US4927829A (en) 1990-05-22
DE68917333D1 (de) 1994-09-15
EP0329126B1 (de) 1994-08-10
JP2668259B2 (ja) 1997-10-27
KR890013015A (ko) 1989-09-20
KR950008313B1 (ko) 1995-07-27
ES2061749T3 (es) 1994-12-16
JPH01308279A (ja) 1989-12-12
DE68917333T2 (de) 1995-03-09

Similar Documents

Publication Publication Date Title
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
DK275488D0 (da) Indolonderivater
FI891980A0 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
NO2011026I1 (no) Eribulin og farmasøytisk akseptable salter derav
DE68924681D1 (de) Heterocyclische Biphosphonsäurederivate.
ES2057126T3 (es) Metodo de tratamiento de la caquexia y algunos nuevos compuestos para utilizar en este metodo.
BR8902929A (pt) Artigo vendavel
DE3874013D1 (de) N-(4-piperidinyl)-bizyklisch kondensierte 2-imidazolamin-derivate.
ATE109780T1 (de) Heterocyclische verbindungen und antiulkusmittel.
ES2073871T3 (es) Tiazolidin-2,4-dionas en el tratamiento de la hipertension.
NO893523L (no) Antihypertensive 3-piperidinyl-indazolderivater.
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
HUT45059A (en) Process for producing abeoergoline derivatives
ATE111462T1 (de) 1,4-dihydropyridin-derivate.
DK0622372T3 (da) Hidtil ukendt forbindelse, Leustroducsin H, dens fremstilling og dens terapeutiske anvendelse

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee